Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 16/20 | 0.80 |
| ▸ | BCL2 | P10415 | 17/20 | 0.79 |
| ▸ | BAD | Q92934 | 3/20 | 0.76 |
| ▸ | BCL2L2 | Q92843 | 2/20 | 0.76 |
| ▸ | BCL2L11 | O43521 | 1/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.76 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.76 |
| ▸ | ASPH | Q12797 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28569997 | 0.92 | BCL2L1 (0.86) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL25600935 | 0.88 | BCL2 (0.80) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL20812412 | 0.88 | BCL2L1 (0.87) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL16974409 | 0.87 | BCL2L1 (0.79) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL16264305 | 0.87 | BCL2L1 (0.78) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19792414 | 0.87 | BCL2L1 (0.86) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL26647951 | 0.87 | BCL2L1 (0.86) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| Navitoclax SCHEMBL10316178 | 0.86 | BCL2L1 (1.00) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| Navitoclax SCHEMBL15005512 | 0.86 | BCL2L1 (1.00) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19091933 | 0.86 | BCL2L1 (0.86) | BCL2L1BCL2BADBCL2L2BCL2L11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116916905-A | Pharmaceutical composition for treating cancer | 塞莱斯蒂亚生物技术股份公司 | 2023-10-20 | — | — | CN | disclosed |